# Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

> **NCT04244084** · PHASE3 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 240 (actual)

## Conditions studied

- Viral Respiratory Infection

## Interventions

- **DRUG:** MMH-407
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04244084
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-08
- **Primary completion:** 2020-04-09
- **Final completion:** 2020-04-09
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04244084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04244084, "Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04244084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*